Amanote Research
Register
Sign In
93. Generation of Gene-Corrected, Vector- And Reprogramming Factor-Free iPS Cells From SCID-X1 Patients
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36665-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2011
Authors
Unknown
Publisher
Elsevier BV
Related search
Gene Correction for SCID-X1 in Long-Term Hematopoietic Stem Cells
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Preclinical Development of Gene Therapy for X-Linked Severe Combined Immunodeficiency (SCID-X1)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-Optimized IL2RG Gene and Minimal Pretransplant Conditioning
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Derivation of Engraftable Myogenic Precursors From Murine ES/iPS Cells and Generation of Disease-Specific iPS Cells From Patients With Duchenne Muscular Dystrophy (DMD) and Other Diseases
Clinical Neurology
Neurology
Differentiation of RPE Cells From Integration-Free iPS Cells and Their Cell Biological Characterization
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
MicroRNA-mediated Reprogramming of Fibroblasts Into Induced Pluripotent Stem (iPS) Cells
Science-Business eXchange
Generation of Transplantable, Vascularized Liver Buds From Induced Pluripotent Stem (iPS) Cells
Science-Business eXchange
Correction To: Differentiation of RPE Cells From Integration-Free iPS Cells and Their Cell Biological Characterization
Stem Cell Research and Therapy
Genetics
Cell Biology
Molecular Biology
Biochemistry
Medicine
Molecular Medicine
The LARGE Principle of Cellular Reprogramming: Lost, Acquired and Retained Gene Expression in Foreskin and Amniotic Fluid-Derived Human iPS Cells
PLoS ONE
Multidisciplinary
